The Blue Matter Breakfast Club is an ongoing series of two-hour breakfast forums, hosted by our team in Europe. These forums are by invitation, bringing together thought leaders and executives from biopharma companies and other organizations to discuss critical business issues.
The fourth Breakfast Club meeting was a virtual event on 13th May 2020. The guest speaker was Dr. Thomas Lönngren, Strategic Advisor and Former Executive Director of the European Medicines Agency (EMA).
The title of the presentation and discussion was Strategic Impact of the Coronavirus Pandemic on Biopharma Companies: R&D, Clinical, and Regulatory. The session included an interview with Dr. Lönngren and a Q&A session with the audience.
